explore -WSS

explore

author：knowledge 2025-09-14 21:55:13 - browse：159

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Pfizer, Moderna say biotech, pharma drug development is a sprint

WSS

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Abortion policy in the spotlight at Republican debate

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Abortion policy in the spotlight at Republican debate

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Pfizer, Moderna say biotech, pharma drug development is a sprint

focus

explore

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

DeSantis wants to import drugs. Biden’s FDA blasted his plan

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Study: Spinal cord stimulation helps patients with paralysis walk again

After affirmative action ruling, medical educators look to 'holistic review'

What Kate Middleton's cancer revelation might teach the world

Anesthesiologist group: stop taking Ozempic before surgery

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Affirmative action in medical school literally saved lives

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

hotspot

Diabetes management: Digital health tools fall short, study says

Yancopoulos of Regeneron works to expand Dupixent success

How to make over

Cancer, immunology, HIV research ensnared in fetal tissue politics

Bring on the sabbaticals for nurses

FDA advisory panel to debate high blood pressure devices

leisure time

Wikipedia

Wikipedia

focus